Trial Profile
Intraoperative Dexamethasone Implant (Ozurdex) Improves Outcome of Cataract Surgery in Patients With Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2014
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 Oct 2012 Planned end date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 14 Mar 2012 New trial record